Compared to Semaglutide and Tirzepatide, retatrutide's special inclusion of glucagon receptor agonism alongside GIP and GLP-one receptor agonism provides a definite pharmacological profile. Although Semaglutide is a GLP-one receptor agonist and Tirzepatide combines GLP-1 and GIP receptor agonism, retatrutide's triple system could perhaps offer broader metabolic Gains. NiceRx is https://corepepptides.com/product/retatrutide-injection-pen/